Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Niemann-Pick C1 (NPC1) messenger RNA is the nucleic acid sequence that encodes the NPC1 protein, a critical mediator of intracellular cholesterol trafficking. Located primarily in the membranes of late endosomes and lysosomes, the resulting NPC1 protein facilitates the egress of unesterified cholesterol into the cytosol for distribution to other organelles (UniProt P11033). Mutations in the NPC1 gene lead to Niemann-Pick disease type C1, a rare and progressive lysosomal storage disorder characterized by severe neurodegeneration and hepatosplenomegaly due to toxic lipid accumulation (NIH MedlinePlus). In drug development, NPC1 mRNA is a primary focus for mRNA replacement therapies, which aim to deliver functional copies of the transcript to restore protein function in patients (Orna Therapeutics). Additionally, the NPC1 protein serves as the essential intracellular receptor for filoviruses, including Ebola and Marburg, making the regulation of its mRNA a potential avenue for antiviral research (PubMed: 21866103). Current therapeutic challenges include the efficient delivery of mRNA across the blood-brain barrier to treat neurological symptoms and managing the potential for innate immune responses to exogenous nucleic acids (PubMed: 32653452).
mRNA replacement therapy (restoration of functional protein expression)
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Niemann-Pick C1 messenger RNA (NPC1 mRNA) (NPC1 mRNA).